Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UPFLOW: Effects of Upadacitinib on T-cell Immune Responses in Rheumatoid Arthritis
jRCT1071260060Recruiting
- Sponsor
- AbbVie Inc.
- Start
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of upadacitinib in rheumatoid arthritis (RA) (5 arms), sponsored by AbbVie Inc. Started Jul 2026; status: recruiting.
02
Drugs
upadacitinib
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on jRCT1071260060.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1071260060.